[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Inherited Cancer Genome Testing Market Growth (Status and Outlook) 2022-2028

November 2022 | 85 pages | ID: GEBB7A0F109BEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to this study, the global Inherited Cancer Genome Testing market size will reach US$ million by 2028.

This report presents a comprehensive overview, market shares, and growth opportunities of Inherited Cancer Genome Testing market by product type, application, key players and key regions and countries.

Segmentation by product type:
  • Breast Cancer
  • Lung Cancer
  • Blood Cancer
  • Liver Cancer
  • Stomach Cancer
  • Others
Segmentation by Application:
  • General Hospitals
  • Specialty Clinics
This report also splits the market by region:
  • United States
  • China
  • Europe
  • Other regions:
    • Japan
    • South Korea
    • Southeast Asia
    • Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
  • 23andMe
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Centogene
  • Color Genomics
  • Gene By Gene
  • Illumina
  • LabCorp
  • Myriad Genetics
  • Positive Bioscience
  • Quest Diagnostics
  • Thermo Fisher Scientific
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Inherited Cancer Genome Testing Market Size 2022-2028
  2.1.2 Inherited Cancer Genome Testing Market Size CAGR by Region
2.2 Inherited Cancer Genome Testing Segment by Type
  2.2.1 Breast Cancer
  2.2.2 Lung Cancer
  2.2.3 Blood Cancer
  2.2.4 Liver Cancer
  2.2.5 Stomach Cancer
  2.2.6 Others
2.3 Inherited Cancer Genome Testing Market Size by Type
  2.3.1 Global Inherited Cancer Genome Testing Market Size Market Share by Type (2022-2028)
  2.3.2 Global Inherited Cancer Genome Testing Market Size Growth Rate by Type (2022-2028)
2.4 Inherited Cancer Genome Testing Segment by Application
  2.4.1 General Hospitals
  2.4.2 Specialty Clinics
2.5 Inherited Cancer Genome Testing Market Size by Application
  2.5.1 Global Inherited Cancer Genome Testing Market Size Market Share by Application (2022-2028)
  2.5.2 Global Inherited Cancer Genome Testing Market Size Growth Rate by Application (2022-2028)

3 INHERITED CANCER GENOME TESTING KEY PLAYERS

3.1 Date of Key Players Enter into Inherited Cancer Genome Testing
3.2 Key Players Inherited Cancer Genome Testing Product Offered
3.3 Key Players Inherited Cancer Genome Testing Funding/Investment Analysis
3.4 Funding/Investment
  3.4.1 Funding/Investment by Regions
  3.4.2 Funding/Investment by End-Industry
3.5 Key Players Inherited Cancer Genome Testing Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions

4 INHERITED CANCER GENOME TESTING BY REGIONS

4.1 Inherited Cancer Genome Testing Market Size by Regions (2022-2028)
4.2 United States Inherited Cancer Genome Testing Market Size Growth (2022-2028)
4.3 China Inherited Cancer Genome Testing Market Size Growth (2022-2028)
4.4 Europe Inherited Cancer Genome Testing Market Size Growth (2022-2028)
4.5 Rest of World Inherited Cancer Genome Testing Market Size Growth (2022-2028)

5 UNITED STATES

5.1 United States Inherited Cancer Genome Testing Market Size by Type (2022-2028)
5.2 United States Inherited Cancer Genome Testing Market Size by Application (2022-2028)

6 CHINA

6.1 China Inherited Cancer Genome Testing Market Size by Type (2022-2028)
6.2 China Inherited Cancer Genome Testing Market Size by Application (2022-2028)

7 EUROPE

7.1 Europe Inherited Cancer Genome Testing Market Size by Type (2022-2028)
7.2 Europe Inherited Cancer Genome Testing Market Size by Application (2022-2028)

8 REST OF WORLD

8.1 Rest of World Inherited Cancer Genome Testing Market Size by Type (2022-2028)
8.2 Rest of World Inherited Cancer Genome Testing Market Size by Application (2022-2028)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 KEY INVESTORS IN INHERITED CANCER GENOME TESTING

10.1 Company A
  10.1.1 Company A Company Details
  10.1.2 Company Description
  10.1.3 Companies Invested by Company A
  10.1.4 Company A Key Development and Market Layout
10.2 Company B
  10.2.1 Company B Company Details
  10.2.2 Company Description
  10.2.3 Companies Invested by Company B
  10.2.4 Company B Key Development and Market Layout
10.3 Company C
  10.3.1 Company C Company Details
  10.3.2 Company Description
  10.3.3 Companies Invested by Company C
  10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……

11 KEY PLAYERS ANALYSIS

11.1 23andMe
  11.1.1 23andMe Company Details
  11.1.2 23andMe Inherited Cancer Genome Testing Product Offered
  11.1.3 23andMe Inherited Cancer Genome Testing Market Size (2022 VS 2027)
  11.1.4 23andMe Main Business Overview
  11.1.5 23andMe News
11.2 Agilent Technologies
  11.2.1 Agilent Technologies Company Details
  11.2.2 Agilent Technologies Inherited Cancer Genome Testing Product Offered
  11.2.3 Agilent Technologies Inherited Cancer Genome Testing Market Size (2022 VS 2027)
  11.2.4 Agilent Technologies Main Business Overview
  11.2.5 Agilent Technologies News
11.3 Bio-Rad Laboratories
  11.3.1 Bio-Rad Laboratories Company Details
  11.3.2 Bio-Rad Laboratories Inherited Cancer Genome Testing Product Offered
  11.3.3 Bio-Rad Laboratories Inherited Cancer Genome Testing Market Size (2022 VS 2027)
  11.3.4 Bio-Rad Laboratories Main Business Overview
  11.3.5 Bio-Rad Laboratories News
11.4 Centogene
  11.4.1 Centogene Company Details
  11.4.2 Centogene Inherited Cancer Genome Testing Product Offered
  11.4.3 Centogene Inherited Cancer Genome Testing Market Size (2022 VS 2027)
  11.4.4 Centogene Main Business Overview
  11.4.5 Centogene News
11.5 Color Genomics
  11.5.1 Color Genomics Company Details
  11.5.2 Color Genomics Inherited Cancer Genome Testing Product Offered
  11.5.3 Color Genomics Inherited Cancer Genome Testing Market Size (2022 VS 2027)
  11.5.4 Color Genomics Main Business Overview
  11.5.5 Color Genomics News
11.6 Gene By Gene
  11.6.1 Gene By Gene Company Details
  11.6.2 Gene By Gene Inherited Cancer Genome Testing Product Offered
  11.6.3 Gene By Gene Inherited Cancer Genome Testing Market Size (2022 VS 2027)
  11.6.4 Gene By Gene Main Business Overview
  11.6.5 Gene By Gene News
11.7 Illumina
  11.7.1 Illumina Company Details
  11.7.2 Illumina Inherited Cancer Genome Testing Product Offered
  11.7.3 Illumina Inherited Cancer Genome Testing Market Size (2022 VS 2027)
  11.7.4 Illumina Main Business Overview
  11.7.5 Illumina News
11.8 LabCorp
  11.8.1 LabCorp Company Details
  11.8.2 LabCorp Inherited Cancer Genome Testing Product Offered
  11.8.3 LabCorp Inherited Cancer Genome Testing Market Size (2022 VS 2027)
  11.8.4 LabCorp Main Business Overview
  11.8.5 LabCorp News
11.9 Myriad Genetics
  11.9.1 Myriad Genetics Company Details
  11.9.2 Myriad Genetics Inherited Cancer Genome Testing Product Offered
  11.9.3 Myriad Genetics Inherited Cancer Genome Testing Market Size (2022 VS 2027)
  11.9.4 Myriad Genetics Main Business Overview
  11.9.5 Myriad Genetics News
11.10 Positive Bioscience
  11.10.1 Positive Bioscience Company Details
  11.10.2 Positive Bioscience Inherited Cancer Genome Testing Product Offered
  11.10.3 Positive Bioscience Inherited Cancer Genome Testing Market Size (2022 VS 2027)
  11.10.4 Positive Bioscience Main Business Overview
  11.10.5 Positive Bioscience News
11.11 Quest Diagnostics
11.12 Thermo Fisher Scientific

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Inherited Cancer Genome Testing Market Size CAGR by Region (2022-2028) ($ Millions)
Table 2. Major Players of Breast Cancer
Table 3. Major Players of Lung Cancer
Table 4. Major Players of Blood Cancer
Table 5. Major Players of Liver Cancer
Table 6. Major Players of Stomach Cancer
Table 7. Major Players of Others
Table 8. Global Inherited Cancer Genome Testing Market Size by Type (2022-2028) ($ Millions)
Table 9. Global Inherited Cancer Genome Testing Market Size Market Share by Type (2022-2028)
Table 10. Global Inherited Cancer Genome Testing Market Size by Application (2022-2028) ($ Millions)
Table 11. Global Inherited Cancer Genome Testing Market Size Market Share by Application (2022-2028)
Table 12. Date of Global Key Players Enter into Inherited Cancer Genome Testing Market
Table 13. Global Key Players Inherited Cancer Genome Testing Product Offered
Table 14. Key Players Inherited Cancer Genome Testing Funding/Investment ($ Millions)
Table 15. Funding/Investment by Regions
Table 16. Funding/Investment by End Industry
Table 17. Key Players Inherited Cancer Genome Testing Valuation & Market Capitalization ($ Millions)
Table 18. Key Players Mergers & Acquisitions, Expansion Plans
Table 19. Inherited Cancer Genome Testing New Product/Technology Launches
Table 20. Inherited Cancer Genome Testing Industry Partnerships, Agreements, and Collaborations
Table 21. Inherited Cancer Genome Testing Industry Mergers and Acquisitions
Table 22. Global Inherited Cancer Genome Testing Market Size by Regions 2022-2028 ($ Millions)
Table 23. Global Inherited Cancer Genome Testing Market Size Market Share by Regions 2022-2028
Table 24. United States Inherited Cancer Genome Testing Market Size by Type (2022-2028) ($ Millions)
Table 25. United States Inherited Cancer Genome Testing Market Size Market Share by Type (2022-2028)
Table 26. United States Inherited Cancer Genome Testing Market Size by Application (2022-2028) ($ Millions)
Table 27. United States Inherited Cancer Genome Testing Market Size Market Share by Application (2022-2028)
Table 28. China Inherited Cancer Genome Testing Market Size by Type (2022-2028) ($ Millions)
Table 29. China Inherited Cancer Genome Testing Market Size Market Share by Type (2022-2028)
Table 30. China Inherited Cancer Genome Testing Market Size by Application (2022-2028) ($ Millions)
Table 31. China Inherited Cancer Genome Testing Market Size Market Share by Application (2022-2028)
Table 32. Europe Inherited Cancer Genome Testing Market Size by Type (2022-2028) ($ Millions)
Table 33. Europe Inherited Cancer Genome Testing Market Size Market Share by Type (2022-2028)
Table 34. Europe Inherited Cancer Genome Testing Market Size by Application (2022-2028) ($ Millions)
Table 35. Europe Inherited Cancer Genome Testing Market Size Market Share by Application (2022-2028)
Table 36. Rest of World Inherited Cancer Genome Testing Market Size by Type (2022-2028) ($ Millions)
Table 37. Rest of World Inherited Cancer Genome Testing Market Size Market Share by Type (2022-2028)
Table 38. Rest of World Inherited Cancer Genome Testing Market Size by Application (2022-2028) ($ Millions)
Table 39. Rest of World Inherited Cancer Genome Testing Market Size Market Share by Application (2022-2028)
Table 40. Key Market Drivers & Growth Opportunities of Inherited Cancer Genome Testing
Table 41. Key Market Challenges & Risks of Inherited Cancer Genome Testing
Table 42. Key Industry Trends of Inherited Cancer Genome Testing
Table 43. Company A Company Details
Table 44. Companies Invested by Company A
Table 45. Company A Key Development and Market Layout
Table 46. Company B Company Details
Table 47. Companies Invested by Company B
Table 48. Company B Key Development and Market Layout
Table 49. Company C Company Details
Table 50. Companies Invested by Company C
Table 51. Company C Key Development and Market Layout
Table 52. Company C Company Details
Table 53. Companies Invested by Company C
Table 54. Company C Key Development and Market Layout
Table 55. 23andMe Basic Information, Head Office, Major Market Areas and Its Competitors
Table 56. 23andMe Inherited Cancer Genome Testing Market Size (2022 VS 2027)
Table 57. Agilent Technologies Basic Information, Head Office, Major Market Areas and Its Competitors
Table 58. Agilent Technologies Inherited Cancer Genome Testing Market Size (2022 VS 2027)
Table 59. Bio-Rad Laboratories Basic Information, Head Office, Major Market Areas and Its Competitors
Table 60. Bio-Rad Laboratories Inherited Cancer Genome Testing Market Size (2022 VS 2027)
Table 61. Centogene Basic Information, Head Office, Major Market Areas and Its Competitors
Table 62. Centogene Inherited Cancer Genome Testing Market Size (2022 VS 2027)
Table 63. Color Genomics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 64. Color Genomics Inherited Cancer Genome Testing Market Size (2022 VS 2027)
Table 65. Gene By Gene Basic Information, Head Office, Major Market Areas and Its Competitors
Table 66. Gene By Gene Inherited Cancer Genome Testing Market Size (2022 VS 2027)
Table 67. Illumina Basic Information, Head Office, Major Market Areas and Its Competitors
Table 68. Illumina Inherited Cancer Genome Testing Market Size (2022 VS 2027)
Table 69. LabCorp Basic Information, Head Office, Major Market Areas and Its Competitors
Table 70. LabCorp Inherited Cancer Genome Testing Market Size (2022 VS 2027)
Table 71. Myriad Genetics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 72. Myriad Genetics Inherited Cancer Genome Testing Market Size (2022 VS 2027)
Table 73. Positive Bioscience Basic Information, Head Office, Major Market Areas and Its Competitors
Table 74. Positive Bioscience Inherited Cancer Genome Testing Market Size (2022 VS 2027)
Table 75. Quest Diagnostics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 76. Quest Diagnostics Inherited Cancer Genome Testing Market Size (2022 VS 2027)
Table 77. Thermo Fisher Scientific Basic Information, Head Office, Major Market Areas and Its Competitors
Table 78. Thermo Fisher Scientific Inherited Cancer Genome Testing Market Size (2022 VS 2027)

LIST OF FIGURES

Figure 1. Picture of Inherited Cancer Genome Testing
Figure 2. Inherited Cancer Genome Testing Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Inherited Cancer Genome Testing Market Size Growth Rate 2022-2028 ($ Millions)
Figure 7. Inherited Cancer Genome Testing Market Size by Region (2022 & 2027) ($ millions)
Figure 8. Global Inherited Cancer Genome Testing Market Size Market Share by Type (2022-2028)
Figure 9. Global Breast Cancer Market Size Growth Rate
Figure 10. Global Lung Cancer Market Size Growth Rate
Figure 11. Global Blood Cancer Market Size Growth Rate
Figure 12. Global Liver Cancer Market Size Growth Rate
Figure 13. Global Stomach Cancer Market Size Growth Rate
Figure 14. Global Others Market Size Growth Rate
Figure 15. Inherited Cancer Genome Testing in General Hospitals
Figure 16. Global Inherited Cancer Genome Testing Market: General Hospitals (2022-2028) ($ Millions)
Figure 17. Inherited Cancer Genome Testing in Specialty Clinics
Figure 18. Global Inherited Cancer Genome Testing Market: Specialty Clinics (2022-2028) ($ Millions)
Figure 19. Global Inherited Cancer Genome Testing Market Size Market Share by Application (2022-2028)
Figure 20. Global Inherited Cancer Genome Testing Market Size in General Hospitals Growth Rate
Figure 21. Global Inherited Cancer Genome Testing Market Size in Specialty Clinics Growth Rate
Figure 22. Funding/Investment
Figure 23. Global Inherited Cancer Genome Testing Market Size Market Share by Regions 2022-2028
Figure 24. United States Inherited Cancer Genome Testing Market Size 2022-2028 ($ Millions)
Figure 25. China Inherited Cancer Genome Testing Market Size 2022-2028 ($ Millions)
Figure 26. Europe Inherited Cancer Genome Testing Market Size 2022-2028 ($ Millions)
Figure 27. Rest of World Inherited Cancer Genome Testing Market Size 2022-2028 ($ Millions)
Figure 28. United States Inherited Cancer Genome Testing Consumption Market Share by Type in 2027
Figure 29. United States Inherited Cancer Genome Testing Market Size Market Share by Application in 2027
Figure 30. China Inherited Cancer Genome Testing Consumption Market Share by Type in 2027
Figure 31. China Inherited Cancer Genome Testing Market Size Market Share by Application in 2027
Figure 32. Europe Inherited Cancer Genome Testing Consumption Market Share by Type in 2027
Figure 33. Europe Inherited Cancer Genome Testing Market Size Market Share by Application in 2027
Figure 34. Rest of World Inherited Cancer Genome Testing Consumption Market Share by Type in 2027
Figure 35. Rest of World Inherited Cancer Genome Testing Market Size Market Share by Application in 2027


More Publications